Stock Price Quote

VANTA BIOSCIENCE LTD.

NSE : NABSE : 540729ISIN CODE : INE695X01011Industry : Business SupportHouse : Private
BSE27.790 (0 %)
PREV CLOSE ( ) 27.79
OPEN PRICE ( ) 27.79
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 750
TODAY'S LOW / HIGH ( )27.79 27.79
52 WK LOW / HIGH ( ) 19.0864.84
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-04 2016
Management Info
- Chairman Dopesh Raja Mulakala - Managing Director
Registered Office

Address No.02/ G/308/ G, No.3/ F F/ S F/1-20-248 ,Umajay Complex,Rasoolpura, Secunderabad,
Hyderabad,
Telangana-500003

Phone 040-6657 5454 / 2790 3226

Email cs@vantabio.com / info@vantabio.com

Website www.vantabio.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE

NEWS

09May Vanta Bioscience informs about disclos
Vanta Bioscience has informed that it enclosed disclosure under Regulati..
06May Allotment of Equity Shares
Interalia, considered and approved the allotment of 8,00,000 (Eight Lakh..
19Sep Vanta Bioscience informs about submiss
In connection with Audited Standalone and Consolidated Financial results..
03Apr Vanta Bioscience bags order of Rs 1.2
Vanta Bioscience has received an order of Rs 1.2 crore from a large Indi..
04Dec Salasar Techno Engineering, Hero MotoC
Salasar Techno Engineering (STEL) has secured an Engineering, Procuremen..

Financials

in Millions
QTR ANNUAL 24
Net Profit0.510000000000002
Gross Profit 0.420000000000002
Operating Profit 37
Net Sales 85.58

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Trishakti Industries (BSE)
peergroup  144.50 (1.76%)
M.Cap ( in Cr)231.89
Sun Pharma Adv. Res (BSE)
peergroup  157.40 (0.64%)
M.Cap ( in Cr)5075.52
Starlog Enterprises (BSE)
peergroup  76.03 (1.00%)
M.Cap ( in Cr)112.67
UTL Industries (BSE)
peergroup  2.88 (2.49%)
M.Cap ( in Cr)9.26
Shangar Decor (BSE)
peergroup  0.74 (-3.90%)
M.Cap ( in Cr)37.70

Shareholding Pattern

PROMOTERS 69.36%
NON-INSTITUTION 30.64%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Vanta Bioscience Ltd.

Vanta Bioscience Ltd. was incorporated in the year 2016. Its today's share price is 27.79. Its current market capitalisation stands at Rs 19.76 Cr. In the latest quarter, company has reported Gross Sales of Rs. 85.58 Cr and Total Income of Rs.86.06 Cr. The company's management includes Sangeetha Padam Choudhary, Yogeswara Rao Danda, Gonuguntla Kathyayani, Padmanabhuni Venkata Appaji, Dopesh Raja Mulakala.

It is listed on the BSE with a BSE Code of 540729 , NSE with an NSE Symbol of and ISIN of INE695X01011. It's Registered office is at No.02/ G/308/ G, No.3/ F F/ S F/1-20-248 ,Umajay Complex,Rasoolpura, SecunderabadHyderabad-500003, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are KBS & Associates, Mathesh & Ramana

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.